Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
Healthcare & PharmaceuticalCompany Update

BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies

August 19, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the completion of the Investigational Medicinal Product Dossier ("IMPD") for BNT23001, the Company's lead proprietary sublingual cladribine oral dissolvable film (ODF) product candidate for the treatment of relapsing forms of multiple sclerosis (MS). Completion of the...

Read more
IRLAB's Drug Candidate IRL757 Receives the Generic Name Linepemat from The WHO
Healthcare & PharmaceuticalCompany Update

IRLAB's Drug Candidate IRL757 Receives the Generic Name Linepemat from The WHO

August 19, 2026 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company focused on discovering and developing new treatments for Parkinson's disease, today announced that the World Health Organization (WHO) has assigned the company's drug candidate IRL757 the unique generic name linepemat. The drug candidate is being developed as a potential first-in-class treatment for apathy associated with Parkinson's disease and other neurological conditions and is currently...

Read more
Cantargia Publishes Half-Year Report 2026
Healthcare & PharmaceuticalEarnings

Cantargia Publishes Half-Year Report 2026

August 19, 2026 1:15 AM

Cantargia AB (publ) (STO:CANTA) today published its interim report for the second quarter and first six months of 2026. "Over the next nine to twelve months, we will lay the groundwork for a broader set of opportunities across the IL1RAP franchise. In PDAC, preparations are in place to initiate the Phase 1b combination study with a RAS inhibitor, which will generate its first clinical readout in this new treatment landscape. In hematology, the...

Read more
Fortifeye Launches Fit Meal and Fit Bites for Nutrition
Healthcare & PharmaceuticalProduct Announcements

Fortifeye Launches Fit Meal and Fit Bites for Nutrition

August 18, 2026 11:59 PM

Fortifeye Vitamins has expanded its nutrition and healthy weight-management portfolio with the introduction of Fortifeye Fit Bites and Fortifeye Fit Meal. The products were developed to address two common challenges associated with healthier eating: finding satisfying options between meals and obtaining convenient, balanced nutrition when preparing a traditional meal is not practical. "Healthy weight management is not about finding one magic...

Read more
Infinx Builds and Scales Workflow-Integrated AI and Agentic Automation on AWS for Healthcare Revenue Cycle
Healthcare & PharmaceuticalProduct Announcements

Infinx Builds and Scales Workflow-Integrated AI and Agentic Automation on AWS for Healthcare Revenue Cycle

August 18, 2026 10:05 PM

Infinx, a provider of healthcare revenue cycle technology and services, today announced expanded use of Amazon Web Services (AWS) as the cloud foundation for its Revenue Cycle Agent Platform, supporting workflow-integrated AI and agentic automation designed for real-world healthcare operations. Infinx is building a Healthcare Revenue Operating System that unifies workflow execution, human-in-the-loop oversight, agent orchestration, monitoring,...

Read more
Protagonist Therapeutics Reports Granting of Inducement Awards
Healthcare & PharmaceuticalCompany Update

Protagonist Therapeutics Reports Granting of Inducement Awards

August 18, 2026 4:05 PM

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on August 17, 2026, it granted inducement awards to two recently hired employees in accordance with the terms of their employment offer letters. The awards were granted under the Protagonist Therapeutics Amended and Restated Inducement Plan, which was adopted May 29, 2018, and amended February 18, 2020 and February 15, 2022. The new employees received, in the aggregate, options to...

Read more
Did The White House And Attorney General Ignore Federal Intel About Marijuana Diversion Through State Licensed Markets?
Healthcare & PharmaceuticalCompany Update

Did The White House And Attorney General Ignore Federal Intel About Marijuana Diversion Through State Licensed Markets?

August 18, 2026 3:05 PM

MMJ International Holdings, Inc. ("MMJ") today announced the first installment of a two-part examination of federal and state law enforcement information concerning illegal marijuana production, inversion and diversion associated with state legal cannabis markets. The first installment examines Oklahoma, California, Oregon, Colorado and Washington. A second installment will examine five additional states and the broader question of whether the...

Read more
PetsForward Announces 'Paws & Purpose' Fundraising Dinner and Comedy Night at Hawkeye & Huckleberry Lounge
Healthcare & PharmaceuticalCompany Update

PetsForward Announces 'Paws & Purpose' Fundraising Dinner and Comedy Night at Hawkeye & Huckleberry Lounge

August 18, 2026 1:20 PM

When medical crises strike a beloved family pet, the intersection of advanced veterinary medicine and financial reality can be overwhelming. Founded by Central Oregon veterinarians who recognized this reality, the non-profit organization PetsForward is working to ensure that financial hardship never stands between a pet and the urgent, advanced care they need. "When a medical emergency impacts a family pet, no loving owner should have to make...

Read more
10 Years, 10 Stories: Four Employees, One Shared Purpose
Healthcare & PharmaceuticalCompany Update

10 Years, 10 Stories: Four Employees, One Shared Purpose

August 18, 2026 11:00 AM

Over the past decade, employees at MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, have turned a global employee volunteer program into a real movement. As SPARK™ marks its 10th anniversary, the "10 Years, 10 Stories" series reflects on a decade of impact and the employees, students, and organizations that have been at the heart of the program. For the first article in this series, MilliporeSigma's...

Read more
CVS Health: Thank You! Enlightenment Plaza Voltaire Villas Volunteer Day in Los Angeles, California
Healthcare & PharmaceuticalCompany Update

CVS Health: Thank You! Enlightenment Plaza Voltaire Villas Volunteer Day in Los Angeles, California

August 18, 2026 11:00 AM

On July 24th, 2026, CVS Health and Aetna colleagues and community organizations came together at Enlightenment Plaza in Los Angeles for a Welcome Home Basket Assembly for residents. Enlightenment Plaza is a recently completed permanent supportive housing community where every unit is reserved for individuals transitioning out of homelessness, serving households at 15%, 20%, 30%, and 50% of Area Median Income. The heart of the day was assembling...

Read more
Eyelid Surgery or Brow Lift? Dr. Homer Hojjat Breaks Down the Difference
Healthcare & PharmaceuticalCompany Update

Eyelid Surgery or Brow Lift? Dr. Homer Hojjat Breaks Down the Difference

August 18, 2026 11:00 AM

Patients who book a consultation for tired-looking eyes usually arrive with a procedure already in mind, and it's not always the one that best fits their anatomy. At SoCal Aesthetic Surgery in Irvine, CA, double board-certified facial plastic surgeon Dr. Homer Hojjat says the choice between treating the eyelid and treating the brow is one of the most common questions raised in his consultations. "That's a good question, and it commonly comes up...

Read more
Rural Health Transformation Requires More Than Funding - It Requires a Proven Care Model
Healthcare & PharmaceuticalCompany Update

Rural Health Transformation Requires More Than Funding - It Requires a Proven Care Model

August 18, 2026 10:00 AM

Rural America does not lack dedicated healthcare professionals. It lacks enough of them. Across the country, rural hospitals and Critical Access Hospitals are being asked to provide increasingly complex care with smaller clinical teams, fewer specialists and greater distances separating patients from higher levels of care. The federal Rural Health Transformation Program (RHTP) creates a historic opportunity to change that. But Avel eCare, a...

Read more
viemaa Launches at Sprouts Farmers Market Nationwide, Advancing a Next-Generation Approach to Bond-Level Hair Repair
Healthcare & PharmaceuticalCompany Update

viemaa Launches at Sprouts Farmers Market Nationwide, Advancing a Next-Generation Approach to Bond-Level Hair Repair

August 18, 2026 10:00 AM

viemaa today announced its national retail launch at Sprouts Farmers Market, expanding access to its Bond Repair System across the United States. The launch reflects continued consumer demand for high-performance haircare formulated at the molecular level, with an emphasis on structural repair rather than surface conditioning. In a category historically dominated by cosmetic smoothing agents, viemaa is engineered around a different principle:...

Read more
Forever Committed to Excellence in Care: DaVita Community Care Report 2025
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Forever Committed to Excellence in Care: DaVita Community Care Report 2025

August 18, 2026 9:35 AM

Throughout DaVita's 25+ year history, we've led the way in patient-centered kidney care. Our work has played a key role in reducing hospitalizations, extending lifespan and helping propel the kidney care community to adopt universally high standards. Since day one, our commitment has never wavered: insistence on high quality and holistic care for every patient we serve. A Decades-Long Legacy of Five-Star Quality As a comprehensive kidney care...

Read more
MDCE Introduces a Higher Standard for Strain Integrity, Potency Verification and Agricultural Quality Control with StrainScan Pro (OTCID:MDCE)
Healthcare & PharmaceuticalCompany Update

MDCE Introduces a Higher Standard for Strain Integrity, Potency Verification and Agricultural Quality Control with StrainScan Pro (OTCID:MDCE)

August 18, 2026 9:17 AM

Medical Care Technologies Inc. (OTCID:MDCE) today highlighted the strategic potential of its StrainScan Pro platform as a proprietary AI vision solution designed to introduce a higher standard for visual quality verification across regulated retail and large-scale agriculture. StrainScan Pro is designed to deliver rapid, on-device visual analysis that supports strain consistency, potency-related visual indicators, and quality verification for...

Read more
Onyx Earns No. 1 Overall Ranking in 2026 Black Book FHIR-Based Payer Interoperability and ePA Report
Healthcare & PharmaceuticalAwards

Onyx Earns No. 1 Overall Ranking in 2026 Black Book FHIR-Based Payer Interoperability and ePA Report

August 18, 2026 9:00 AM

Black Book Market Research today announced that Onyx ranked first overall in its Q3 2026 Top FHIR-Based Payer Interoperability & Electronic Prior Authorization Solutions report. Onyx achieved more category-leading results than any other evaluated solution, ranking first in 11 of the 18 key performance indicators used to assess payer interoperability and electronic prior authorization platforms. "Onyx's breadth of leadership is what distinguishes...

Read more
Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates
Healthcare & PharmaceuticalConference Call

Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates

August 18, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Wednesday, August 19, 2026 at 4:30 p.m. Eastern to review second-quarter 2026 financials and provide corporate updates. Participation Instructions for Jaguar Health Investor Webcast When: Wednesday, August 19, 2026 at 4:30 p.m. Eastern Participant Registration & Access Link: Click Here Replay: A replay of the webcast will be available on the...

Read more
The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon
Healthcare & PharmaceuticalRegulatory

The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon

August 18, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus and other Ebola viruses is expected to begin soon in the Democratic Republic of Congo ("DRC"). Professor Patrick Katoto has been appointed as the principal investigator to lead this clinical...

Read more
Protect Pharmaceutical Corp. Announces Closing of Environmental Infrastructure Acquisitions
Healthcare & PharmaceuticalMergers and Acquisitions

Protect Pharmaceutical Corp. Announces Closing of Environmental Infrastructure Acquisitions

August 18, 2026 8:00 AM

Protect Pharmaceutical Corp. (OTCID:PRTT) (the "Company" or "PRTT") today announced that its wholly owned Canadian subsidiary has completed the acquisition of Vacterra Hydrovac Inc. ("Vacterra") and Clearwater Environmental Ltd. ("Clearwater") from Horizon Enterprises Ltd. ("Horizon"), together with the acquisition of Arvia Environmental Systems Inc. ("Arvia"). The combined gross revenue for Vacterra and Clearwater during the fiscal year ended...

Read more
State of Medicaid Enterprise Technology 2026-2028 Identifies 14 Modeled Category Leaders Heading into the 2027 Implementation Cycle, Reports Black Book
Healthcare & PharmaceuticalConferences

State of Medicaid Enterprise Technology 2026-2028 Identifies 14 Modeled Category Leaders Heading into the 2027 Implementation Cycle, Reports Black Book

August 18, 2026 7:25 AM

Black Book Research today announced the release of State of Medicaid Enterprise Technology 2026-2028, a 261-page national buyer-intelligence, market-opportunity and vendor-benchmark study developed for state Medicaid executives, Medicaid Enterprise Systems leaders, CIOs, enterprise architects, operations teams, managed-care organizations, procurement officials and the technology and services firms supporting them. The report evaluates Medicaid...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?